FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News

Ad Price Disclosure Ill-Conceived, Illegal: WLF

Attorney Howard Dorfman says the CMS proposal to require companies to include the prescription drug wholesale acquisition price in DTC ads is ill-conc...

Human Drugs

NDA/ANDA User Fee Acceptance Dates for Shutdown Filings

An FDA notice outlines NDA/BLA/ANDA user fee acceptance dates for submissions received during the partial government shutdown.

Medical Devices

MediPines Gas Exchange Monitor Cleared

FDA clears a MediPines 510(k) for the MediPines Gas Exchange Monitor, which is intended for real-time pulmonary parameters and insights to support rap...

Human Drugs

Doctors Concerns About FDA Approvals, Off-Label Marketing

Researchers say most doctors surveys are concerned about FDA accelerated drug approvals and dont like eased restrictions on off-label marketing.

FDA General

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that include Hangzhou Guoguang Touring Commodity Co. and University of Miami Reproductive and Fertili...

Human Drugs

Drug Product Electronic Application Submission Guidance

FDA issues a guidance extending the implementation date for electronic format submissions of Type 3 drug master files.

FDA General

FDA Not Consistent with Common Rule: Attorneys

Morgan Lewis attorneys say FDA promises to write rules in the future to better align its human subject protection regulations with the new federal Com...

Human Drugs

FDA Generic Drug Inspections, Enforcement Down: Bloomberg News

A year-long Bloomberg News investigation highlights concerns that FDA generic drug surveillance inspections have been dropping while the number of app...

Human Drugs

FDA Warns Miami University Fertility Center

FDA sends University of Miami Reproductive and Fertility Center a Warning Letter for significant deviations from the regulations for human cells, tiss...

Human Drugs

FDA OKs I-Mab Biopharma IND for Cancer Immunotherapy

FDA approves an I-Mab Biopharma IND for TJC4, a human anti-CD47 monoclonal antibody for cancer immunotherapy.